Achaiah Garlapati

651 total citations
36 papers, 551 citations indexed

About

Achaiah Garlapati is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Achaiah Garlapati has authored 36 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 12 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Achaiah Garlapati's work include Synthesis and biological activity (21 papers), Synthesis and Characterization of Heterocyclic Compounds (10 papers) and Computational Drug Discovery Methods (10 papers). Achaiah Garlapati is often cited by papers focused on Synthesis and biological activity (21 papers), Synthesis and Characterization of Heterocyclic Compounds (10 papers) and Computational Drug Discovery Methods (10 papers). Achaiah Garlapati collaborates with scholars based in India, Germany and China. Achaiah Garlapati's co-authors include Vobalaboina Venkateswarlu, G. Narahari Sastry, Chandrashekhar V. Mangannavar, Stefan Laufer, Dileep Kumar, Chandrakant Bagul, Someswar Rao Sagurthi, Perugu Shyam, G. L. David Krupadanam and Banoth Karan Kumar and has published in prestigious journals such as SHILAP Revista de lepidopterología, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

Achaiah Garlapati

35 papers receiving 535 citations

Peers

Countries citing papers authored by Achaiah Garlapati

Since Specialization

Citations

This map shows the geographic impact of Achaiah Garlapati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achaiah Garlapati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achaiah Garlapati more than expected).

Fields of papers citing papers by Achaiah Garlapati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Achaiah Garlapati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achaiah Garlapati. The network helps show where Achaiah Garlapati may publish in the future.

Co-authorship network of co-authors of Achaiah Garlapati

This figure shows the co-authorship network connecting the top 25 collaborators of Achaiah Garlapati. A scholar is included among the top collaborators of Achaiah Garlapati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Achaiah Garlapati. Achaiah Garlapati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, Synthesis, Molecular Docking, Antitubercular, Antimicrobial and Antioxidant Studies of Some Novel 3-(((1H-Benzo[d]imidazol-2-yl)methyl)thio)-5H-[1,2,4] Triazino[5,6-b]indole Derivatives 2023 ·International Journal of Pharmaceutical Sciences and Drug Research ·(unknown), (unknown), (unknown), Achaiah Garlapati	1
2	Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectives 2022 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·(unknown), Chandrakant Bagul, Dileep Kumar, (unknown), Achaiah Garlapati, (unknown)	24
3	Design, synthesis, in silico studies, and evaluation of novel chalcones and their pyrazoline derivatives for antibacterial and antitubercular activities 2020 ·Medicinal Chemistry Research ·(unknown), Banoth Karan Kumar, Sankaranarayanan Murugesan, (unknown), Achaiah Garlapati	26
4	Design, Synthesis and Evaluation of Aryloxybenzylidene Hydrazinyl-Benzoxazoles/Benzothiazoles Analogs as Antimycobacterial Agents 2020 ·(unknown), (unknown), (unknown), (unknown), Shravan Kumar Gunda, Achaiah Garlapati	2
5	Multidrug Resistance Reversal Activity of Some New Dihydropyridines Studied by IN SITU Single-Pass Intestinal Perfusion (SPIP) Method in Rat 2018 ·Pharmaceutical Chemistry Journal ·(unknown), Achaiah Garlapati, Narayan Prasad, (unknown), (unknown), (unknown)	5
6	Substituted Benzamides from Anti-inflammatory and p38 Kinase Inhibitors to Antitubercular Activity: Design, Synthesis and Screening 2018 ·Mini-Reviews in Medicinal Chemistry ·(unknown), (unknown), Achaiah Garlapati, Stefan Laufer, (unknown), V. Chandrashekar, (unknown), (unknown), (unknown)	6
7	Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: Synthesis and SAR studies 2014 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), (unknown), G. Narahari Sastry, (unknown), Achaiah Garlapati	14
8	Rational design and synthesis of novel 2-(substituted-2H-chromen-3-yl)-5-aryl-1H-imidazole derivatives as an anti-angiogenesis and anti-cancer agent 2014 ·RSC Advances ·(unknown), Someswar Rao Sagurthi, Perugu Shyam, Achaiah Garlapati, G. L. David Krupadanam	23
9	Design, Synthesis and Characterization of N', N'-Diaryl Ureas as p38 Kinase Inhibitors 2013 ·Medicinal Chemistry ·(unknown), Stefan Laufer, Chandrashekhar V. Mangannavar, Achaiah Garlapati	11
10	Synthesis, p38 Kinase Inhibitory and Anti-inflammatory Activity of New Substituted Benzimidazole Derivatives 2012 ·Medicinal Chemistry ·(unknown), Stefan Laufer, Chandrashekhar V. Mangannavar, Achaiah Garlapati	16
11	Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines 2011 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Achaiah Garlapati, (unknown)	83
12	Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors 2011 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Umasankar Kulandaivelu, Mahendar Porika, Sadanandam Abbagani, Achaiah Garlapati, (unknown)	25
13	Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives and evaluation of their activities against human colon cancer cell lines 2010 ·European Journal of Medicinal Chemistry ·(unknown), Achaiah Garlapati	41
14	Synthesis and Anti-platelet Activity of 3-phenyl-4(1H)-quinolones 2010 ·International Journal of Pharmaceutical Sciences and Nanotechnology ·Achaiah Garlapati, (unknown), (unknown)	1
15	Facile Synthesis and Antibacterial, Antitubercular, and Anticancer Activities of Novel 1,4‐Dihydropyridines 2010 ·Archiv der Pharmazie ·(unknown), Achaiah Garlapati, (unknown)	82
16	Synthesis and pharmacological evaluation of (6-substituted 4-Oxo-4<i> H</i> -chromene-3 yl) methyl N-substituted aminoacetates 2008 ·Indian Journal of Pharmaceutical Sciences ·Achaiah Garlapati, (unknown), (unknown)	6
17	Strategies to design pyrazolyl urea derivatives for p38 kinase inhibition: a molecular modeling study 2007 ·Journal of Computer-Aided Molecular Design ·(unknown), (unknown), Achaiah Garlapati, G. Narahari Sastry	16
18	Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking☆ 2007 ·European Journal of Medicinal Chemistry ·(unknown), Achaiah Garlapati, G. Narahari Sastry	37
19	Quaternary salts of 4,3′ and 4,4′ bis-pyridinium monooximes: Synthesis and biological activity 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Vobalaboina Venkateswarlu, Achaiah Garlapati	38
20	Synthesis of 2 methyl 4 oxo n 4 oxo 2 arylthiazolidin 3 yl 3 4h quinazolineacetamides 1988 ·Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry ·A. Mallikarjun, Achaiah Garlapati, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact